文献速递肝胆胰外科

保留肝实质策略下腔静脉汇合处结直肠癌肝转移的肝静脉处理

Hepatic vein management in a parenchyma-sparing policy for resecting colorectal liver metastases at the caval confluence.
PubMed 文献 · Surgery · 2017-11-21

该回顾性队列分析135例结直肠癌肝转移与腔静脉汇合处肝静脉接触的患者共190处接触,系统尝试肝静脉-肿瘤分离或保留引流肝实质的切除。结果显示76%患者可行保留肝静脉切除,仅0.7%需大范围肝切除,手术死亡率0.7%,局部复发率6%,术前术中影像预测肝静脉切除需求准确率99%。

要点

  • 按肿瘤与肝静脉周径接触比例分型(<1/3、1/3–2/3、>2/3)指导手术决策。
  • 系统尝试肝静脉分离或部分切除修补,多数患者可避免大范围肝切除。
  • 术前术中影像可高度准确预测肝静脉切除需求(κ=0.971)。

核心结论

  • 对腔静脉汇合处结直肠癌肝转移-肝静脉接触患者,保留肝静脉或保留肝实质策略在多数患者中可行。
  • 该策略安全、可预测且肿瘤学充分,经进一步确认后或可替代大范围肝切除或肝静脉置换。

研究设计与样本

  • 回顾性队列研究,连续纳入135例结直肠癌肝转移与腔静脉汇合处肝静脉接触并接受肝手术的患者。
  • 共分析190处结直肠癌肝转移-肝静脉接触,按接触/受累周径比例分为Type 1(<1/3)、Type 2(1/3–2/3)、Type 3(>2/3)。
  • 系统尝试肝静脉-结直肠癌肝转移分离,若需肝静脉切除则保留引流肝实质。

主要发现

  • 肝静脉-结直肠癌肝转移分离在95处(50%)接触中实施,部分切除直接缝合61处(32%),部分切除补片4处(2%),肝静脉完全切除30处(16%)。
  • 102例(76%)患者可行保留肝静脉的切除,仅1例(0.7%)需大范围肝切除。
  • 手术死亡率0.7%,总并发症率32%,主要并发症率4%,局部复发率6%(中位随访27个月)。

关键数值与推荐

  • 术前和术中影像预测肝静脉切除需求的准确率为99%(κ=0.971)。
  • 接触/受累周径分型:Type 1 <1/3,Type 2 1/3–2/3,Type 3 >2/3。

临床怎么用

  • 对腔静脉汇合处肝静脉接触的结直肠癌肝转移,可优先尝试肝静脉分离或保留肝实质的切除,避免常规大范围肝切除。
  • 利用术前和术中影像预测肝静脉切除需求,辅助制定保留肝实质的手术规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with tumors involving hepatic vein at the caval-confluence usually receive major hepatectomies or hepatic vein grafting; however, nonnegligible postoperative mortality and morbidity are associated. Authors introduced the tumor-vessel detachment for colorectal liver metastases. Then we reviewed our results applying this approach in patients with colorectal liver metastases in contact with hepatic veins at the caval-confluence. METHODS: A cohort of consecutive patients with colorectal liver metastases in contact with hepatic veins at the caval-confluence undergoing liver surgery was reviewed. Relationships were classified as: Type 1: contact/involvement less than a third of hepatic vein circumference; Type 2: contact/involvement in a third to two-thirds; Type 3: contact/involvement in more than two-thirds. Hepatic vein- colorectal liver metastases detachment, or in case of hepatic vein-resection, the sparing of the drained parenchyma, were attempted systematically. RESULTS: Overall 190 colorectal liver metastases-hepatic vein contacts in 135 patients were analyzed. Colorectal liver metastases-hepatic vein detachment was performed in 95 (50%) contacts, partial resection and direct suture in 61 (32%), partial resection and patching in 4 (2%), and hepatic vein complete resection in 30 (16%). Hepatic vein-sparing resection was possible in 102 patients (76%), and major hepatectomy was needed in 1 (0.7%). Operative mortality, overall and major morbidity rate were 0.7%, 32%, and 4%, respectively. Local recurrence rate was 6% (median follow-up: 27 months). Preoperative and intraoperative imaging predicted the need for hepatic vein resection in 99% of patients (κ = 0.971). CONCLUSIONS: Hepatic vein-sparing or a parenchyma-sparing policy is feasible in most patients with colorectal liver metastases-hepatic vein contacts at the caval-confluence. This approach seems safe, predictable, and oncologically adequate, and, upon further confirmation, could become an alternative to major hepatectomies or hepatic vein replacement.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Torzilli G, Procopio F, Viganò L, et al. Hepatic vein management in a parenchyma-sparing policy for resecting colorectal liver metastases at the caval confluence. Surgery. 2017. PMID: 29169612. doi:10.1016/j.surg.2017.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。